NYSE:BMY

Bristol-myers Squibb Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy BMY

*Your capital is at risk

$59.34

+1.76 (+3.06%)

At Close: Jul 13, 2026

Bristol-Myers Squibb Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 22.43. In total, the insiders bought 615.04M and sold 104.24K BMY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	22.43
● Buy	615.04M shares
● Sell	104.24K shares
62% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Apr 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 22.43. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 30, 2026 Buy	Deferred Share Units A-Award	Samuels Theodore R. Ii Director	Director	889 Value: $51.2K
Jun 30, 2026 Buy	Deferred Share Units A-Award	Arduini Peter J Director	Director	607 Value: $35.0K
Jun 30, 2026 Buy	Deferred Share Units A-Award	Mcmullen Michael R. Director	Director	607 Value: $35.0K
Jun 30, 2026 Buy	Deferred Share Units A-Award	Rice Derica W Director	Director	673 Value: $38.8K
Jun 30, 2026 Buy	Deferred Share Units A-Award	Yale Phyllis R Director	Director	607 Value: $35.0K
Jun 15, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Haller Julia A Director	Director	20 460 Value: $1.10M
Jun 15, 2026 Buy	Option (right to buy) M-Exempt	Haller Julia A Director	Director	20 460 Value: $1.10M
Jun 03, 2026 Sell	Common Stock, $0.10 par value F-InKind	Short Bartie Wendy EVP, Corporate Affairs	Officer	3 876 Value: $212.1K
Jun 03, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	8 040 Value: $439.9K
Jun 03, 2026 Buy	Restricted Stock Units M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	8 040 Value: $439.9K
May 01, 2026 Buy	Market Share Units M-Exempt	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	1 373 Value: $79.9K
May 01, 2026 Sell	Common Stock, $0.10 par value F-InKind	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	599 Value: $34.9K
May 01, 2026 Sell	Common Stock, $0.10 par value J-Other	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	203 Value: $0
May 01, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	1 373 Value: $79.9K
Apr 01, 2026 Sell	Common Stock, $0.10 par value F-InKind	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	1 692 Value: $104.4K
Apr 01, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	3 307 Value: $204.1K
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	3 307 Value: $204.1K
Apr 01, 2026 Sell	Common Stock, $0.10 par value S-Sale	Elkins David V EVP, Chief Financial Officer	C-Suite Officer	25 519 Value: $1.57M
Apr 01, 2026 Sell	Common Stock, $0.10 par value S-Sale	Elkins David V EVP, Chief Financial Officer	C-Suite Officer	4 481 Value: $278.0K
Mar 31, 2026 Buy	Deferred Share Units A-Award	Arduini Peter J Director	Director	577 Value: $35.0K
Mar 31, 2026 Buy	Deferred Share Units A-Award	Rice Derica W Director	Director	639 Value: $38.8K
Mar 31, 2026 Buy	Deferred Share Units A-Award	Yale Phyllis R Director	Director	577 Value: $35.0K
Mar 31, 2026 Buy	Deferred Share Units A-Award	Samuels Theodore R. Ii Director	Director	845 Value: $51.2K
Mar 31, 2026 Buy	Deferred Share Units A-Award	Mcmullen Michael R. Director	Director	577 Value: $35.0K
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	2 146 Value: $129.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BRISTOL-MYERS SQUIBB COMPANY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th...

Read Full Profile Here